Press Releases

Date	Title and Summary	Additional Formats
Toggle SummaryMar 30, 2016	Agile Therapeutics to Present at the 15th Annual Needham Healthcare Conference Presentation Scheduled on Wednesday, April 13, 2016 at 4:20 PM Eastern Time...	Agile Therapeutics to Present at the 15th Annual Needham Healthcare Conference 14.9 KB
Toggle SummaryMar 9, 2016	Agile Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results Cash Expected to Fund Operations Through the End of 2017...	Agile Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results 34.7 KB
Toggle SummaryMar 3, 2016	Agile Therapeutics to Present at the 28th Annual ROTH Conference Presentation Scheduled on Monday, March 14, 2016 at 7:30 AM Pacific Time...	Agile Therapeutics to Present at the 28th Annual ROTH Conference 14.3 KB
Toggle SummaryFeb 24, 2016	Agile Therapeutics Appoints Ajit S. Shetty, Ph.D., to Its Board of Directors Andrew Schiff, M.D. to Step Down From the Board...	Agile Therapeutics Appoints Ajit S. Shetty, Ph.D., to Its Board of Directors 16 KB
Toggle SummaryFeb 16, 2016	Agile Therapeutics to Present at the 2016 RBC Capital Markets' Global Healthcare Conference Presentation Scheduled on Tuesday, February 23, 2016 at 8:00 AM ET ...	Agile Therapeutics to Present at the 2016 RBC Capital Markets' Global Healthcare Conference 14.3 KB
Toggle SummaryFeb 4, 2016	Agile Therapeutics, Inc. Announces Full Exercise of Option to Purchase Additional Shares by Underwriters PRINCETON, N.J., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that the underwriters of its previously announced...	Agile Therapeutics, Inc. Announces Full Exercise of Option to Purchase Additional Shares by Underwriters 18 KB
Toggle SummaryJan 22, 2016	Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock PRINCETON, N.J., Jan. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced the pricing of its underwritten public offering...	Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock 18.1 KB
Toggle SummaryJan 21, 2016	Agile Therapeutics Announces Proposed Offering of Common Stock PRINCETON, N.J., Jan. 21, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that it intends to offer and sell $30 million of...	Agile Therapeutics Announces Proposed Offering of Common Stock 16.7 KB
Toggle SummaryJan 15, 2016	Agile Therapeutics to Present at Noble Financial Capital Markets' Twelfth Annual Equity Conference Presentation Scheduled on Monday, January 18, 2016 at 11:30 AM ET ...	Agile Therapeutics to Present at Noble Financial Capital Markets' Twelfth Annual Equity Conference 13 KB
Toggle SummaryDec 1, 2015	Agile Therapeutics Receives Approximately $6 Million in Non-Dilutive Funding From New Jersey's Technology Business Tax Certificate Transfer Program PRINCETON, N.J., Dec. 01, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced today that it has received net proceeds of approximately $6 million in...	Agile Therapeutics Receives Approximately $6 Million in Non-Dilutive Funding From New Jersey's Technology Business Tax Certificate Transfer Program 16.5 KB